Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Change in Receivables (2021 - 2025)

Historic Change in Receivables for IceCure Medical (ICCM) over the last 5 years, with Q3 2025 value amounting to $18000.0.

  • IceCure Medical's Change in Receivables fell 9027.03% to $18000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $36000.0, marking a year-over-year increase of 21250.0%. This contributed to the annual value of -$118000.0 for FY2024, which is 37200.0% down from last year.
  • Per IceCure Medical's latest filing, its Change in Receivables stood at $18000.0 for Q3 2025, which was down 9027.03% from $178000.0 recorded in Q2 2025.
  • IceCure Medical's 5-year Change in Receivables high stood at $355000.0 for Q4 2021, and its period low was -$638000.0 during Q4 2022.
  • For the 5-year period, IceCure Medical's Change in Receivables averaged around -$23416.7, with its median value being -$3500.0 (2022).
  • The largest annual percentage gain for IceCure Medical's Change in Receivables in the last 5 years was 175000.0% (2024), contrasted with its biggest fall of 172000.0% (2024).
  • Over the past 5 years, IceCure Medical's Change in Receivables (Quarter) stood at $355000.0 in 2021, then tumbled by 279.72% to -$638000.0 in 2022, then soared by 100.78% to $5000.0 in 2023, then tumbled by 1720.0% to -$81000.0 in 2024, then soared by 122.22% to $18000.0 in 2025.
  • Its Change in Receivables was $18000.0 in Q3 2025, compared to $178000.0 in Q2 2025 and -$79000.0 in Q1 2025.